Login / Signup

Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.

Ioannis I SpiliotisRod ChalkStephen GoughPatrik Rorsman
Published in: Diabetes, obesity & metabolism (2022)
Keyphrases
  • low dose
  • type diabetes
  • high dose
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • skeletal muscle
  • adipose tissue